Dr. Reddy's Laboratories (ADR)
Produces generics, branded medicines, biosimilars, active ingredients, and consumer health products.
$12.18
After-hours close0.00 (0.00%)
At close$12.18(+0.16%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 15.08%125.61M sharesInsiders 0.01%55.8K sharesOther 84.91%707.28M shares
Shares outstanding 832.95M · Float 832.95M · 100.0% free float
Institutions13F, as of Jun 30, 2026
240 holders · 125.61M shares · 31 new positions · 107 increased · 98 reduced · 41 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Robeco Institutional Asset Management B.V. | 18.02M | 2.16% | +843.2K | Jul 21, 2026 |
| Morgan Stanley | 10.94M | 1.31% | +1.56M | Aug 13, 2026 |
| BlackRock, Inc. | 10.59M | 1.27% | −1.00M | Aug 7, 2026 |
| Royal Bank of Canada | 9.21M | 1.11% | −770.8K | Aug 14, 2026 |
| Aikya Investment Management Ltd | 8.49M | 1.02% | +494.1K | Aug 12, 2026 |
| Renaissance Technologies LLC | 7.35M | 0.88% | −512.7K | Aug 13, 2026 |
| Dimensional Fund Advisors LP | 5.31M | 0.64% | −11.2K | Aug 11, 2026 |
| State Street Corp | 4.12M | 0.50% | +98.5K | Aug 7, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| K. Satish Reddyincl. GVP Family Trust, Deepti Reddy +3 more | 13.58% | 113.36M | 13D | Sep 18, 2025 ↗ |
| BlackRock, Inc. | 5.30% | Oct 24, 2024 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Milan Kantilal Kalawadia | officer: CEO - North America | 47.3K | 0.01% | Apr 1, 2026 |
| Patrick Rudolf Aghanian | officer: Head - Europe Generics | 8.5K | 0.00% | Apr 1, 2026 |
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.